Showing Results for
- Academic Journals (36,541)
Search Results
- 36,541
Academic Journals
- 36,541
-
From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 2)AUVI-Q Sanofi Aventis Rx Sympathomimetic. Epinephrine 0.3mg, 0.15mg; pre-filled auto-injector (includes audible and visible cues for use). Indications: Emergency treatment of allergic reactions (Type 1) including...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 16, Issue 3) Peer-ReviewedEffient (prasugrel tablets, from Daiichi Sankyo and Lilly), has been approved to reduce thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with...
-
From:Physician Assistants' Prescribing Reference (Vol. 20, Issue 2)LEVOTHROID Forest Rx T4 (synthetic). Levothyroxine sodium 25mcg, 50mcg, 75mcg, 88mcg, 100mcg, 112mcg, 125mcg, 137mcg, 150mcg, 175mcg, 200mcg, 300mcg; tabs. Indications: Hypothyroidism. Adults: Maintenance:...
-
From:MPR - Physician Assistants' Edition (Vol. 23, Issue 2)Bococizumab (Pfizer) an injectable proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor being investigated for the reduction of LDL-C in patients with hyperlipidemia or mixed dyslipidemia--Phase 3...
-
From:Physician Assistants' Prescribing Reference (Vol. 16, Issue 4)The FDA has approved Micardis 80mg (telmisartan tablets, from Boehringer Ingelheim) for the reduction of the risk of MI, stroke, or death from cardiovascular causes in patients [greater than or equal to] 55 years old at...
-
From:Nurse Practitioners' Prescribing Reference (Vol. 22, Issue 4) Peer-Reviewed> ACCUPRIL Pfizer Rx ACE inhibitor. Quinapril (as HCl) 5mg+, 10mg, 20mg, 40mg; tabs; +scored. Indications: Heart failure inadequately controlled by diuretics and/or digitalis. Adults: Initially 5mg twice daily,...
-
From:MPR - Physician Assistants' Edition (Vol. 20, Issue 3)EVOXAC Daiichi Sankyo Rx Cholinergic (muscarinic) agonist. Cevimeline HCI 30mg; caps. Indications: Dry mouth associated with Sjogren's syndrome. Adults: 30mg three times daily. Children: Not recommended....
-
From:Nurse Practitioners' Prescribing Reference (Vol. 16, Issue 4) Peer-ReviewedThe FDA has approved Micardis 80mg (telmisartan tablets, from Boehringer Ingelheim) for the reduction of the risk of MI, stroke, or death from cardiovascular causes in patients [greater than or equal to] 55 years old at...
-
From:International Journal of Nutrition, Pharmacology, Neurological Diseases (Vol. 2, Issue 3)Byline: Raveendranadh. Pilli, MUR. Naidu, Usha. Pingali, Ramesh Kumar. Takallapally Introduction: Caffeine is one of the most widely used pharmacologically active substances. It increases blood pressure and...
-
From:Diabetes Care (Vol. 36, Issue 3) Peer-ReviewedOBJECTIVE--To examine the association between genetic predisposition to type 2 diabetes (T2D) and risk of cardiovascular disease (CVD) among patients with T2D. RESEARCH DESIGN AND METHODS--The current study included...
-
From:Future Cardiology (Vol. 9, Issue 2) Peer-ReviewedAuthor(s): Satsuki Fukushima 1 , Yoshiki Sawa 1 , Ken Suzuki [*] 2 Keywords * cell-delivery route; cell transplantation; heart failure; intracoronary injection; intramyocardial injection; regenerative medicine;...
-
From:Health Services Research (Vol. 48, Issue 3) Peer-ReviewedObjective. Older persons with coronary heart disease have reduced access to appropriate medical and surgical services if they are also mentally ill. This study determined whether difference exists in access to hospitals...
-
From:North American Journal of Medical Sciences (Vol. 5, Issue 8) Peer-ReviewedByline: Jacinta. Uzoigwe, Thavaleak. Prum, Eric. Bresnahan, Mahdi. Garelnabi Outdoor and indoor air pollution poses a significant cardiovascular risk, and has been associated with atherosclerosis, the main underlying...
-
From:Clinical Practice (Vol. 10, Issue 5) Peer-ReviewedAuthor(s): Robert S Dieter 1 The Risk and Prevention Study Collaborative Group. n-3 fatty acids in patients with multiple cardiovascular risk factors. N. Engl. J. Me d. 368, 1800-1808 (2013). Fish consumption has...
-
From:Internal Medicine News (Vol. 46, Issue 17)FROM BMJ Exercise may be at least as effective as drug interventions with respect to mortality outcomes for secondary prevention of coronary heart disease. A "meta-epidemiological" study of 12 drug-related...
-
From:North American Journal of Medical Sciences (Vol. 5, Issue 9) Peer-ReviewedByline: Avupati. Syamsunder, Gopal. Pal, Pravati. Pal, Chandrakasan. Kamalanathan, Subhash. Parija, Nivedita. Nanda Background: Cardiovascular morbidities have been reported in hypothyroidism. Aims: The objective of...
-
From:Clinical Practice (Vol. 11, Issue 1) Peer-ReviewedAuthor(s): Olov Wiklund [*] 2 , Carlo Pirazzi 1 , Stefano Romeo 1 Practice Points * Dyslipidemia is a risk factor for cardiovascular disease (CVD) in older adults. * Statin treatment should always be considered...
-
From:Journal of Postgraduate Medicine (Vol. 59, Issue 4) Peer-ReviewedByline: RAB. Carey, P. Rupali, O. Abraham, D. Kattula Context: Antiretroviral therapy (ART) is associated with a myriad of metabolic complications which are potential cardiovascular risk factors. Early detection of...
-
From:Avicenna Journal of Medicine (Vol. 4, Issue 1) Peer-ReviewedByline: Mohammed. Chamsi-Pasha, Hassan. Chamsi-Pasha Ibn Sina, known in the West as Avicenna, was the most famous and influential of all the Islamic philosopher-scientists. His most important medical works are the...
-
From:Maternal and Child Health Journal (Vol. 17, Issue 3) Peer-ReviewedPregnancy is associated with alterations in low-density lipoprotein (LDL) and high-density lipoprotein (HDL) subclasses, but the exact pattern of these variations remains controversial. This study investigates...